The Effect of XSurge Supplementation on Biomarkers and Performance From High Intensity Resistance Exercise

Kemin Foods

Status: Completed

Conditions: Exercise Performance Recovery

Treatments: Dietary Supplement: XSurge; Other: Control: No supplementation; Other: Placebo: Microcrystalline Cellulose

Study type: Interventional

Funder types: Industry

Identifiers

NCT02442245

14HUS002

Details and patient eligibility

About

Part one of this study will consist of baseline (BL) testing, 28 days of daily supplementation with XSurge, and an exercise protocol. The acute exercise protocol consists of five visits, of which, the first visit will consist of maximal strength testing. The remaining visits will consist of performance testing and muscle evaluation.

Phase two of this study will consist of six weeks of supervised resistance training along with supplementation of XSurge. Following the six weeks of training, subjects will complete a second acute exercise protocol. Measures to be evaluated will consist of performance testing and muscle evaluation.

Enrollment: 41 patients

Sex: Male

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Recreationally active.
• Subject is judged by the Investigator to be healthy and free of any physical limitations
• Subject is male 18-35 y of age, inclusive
• Subject has a body mass index of 18.0-34.9 kg/m2
• Subject is willing to maintain habitual diet
• Subject is willing to abstain from dietary supplementation
• Subject understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators

Exclusion criteria

• Subject is currently or will be enrolled in another clinical trial.
• Subject has a history or presence of a clinically relevant cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder.
• Subject has a history or presence of cancer in the prior 2 years, except for non-melanoma skin cancer.
• Subject is unable to perform physical exercise
• Subject is a current smoker or has quit within the last 6 months
• Subject is engaged in an extreme diet including but not limited to, Atkins, South Beach, Intermittent Fasting, etc.
• Subject is allergic to the study product or placebo
• Subject is taking any other nutritional supplement or performance enhancing drug
• Subjects that have donated blood or plasma within the previous week
• Subject has any chronic illness that causes continuous medical care
• Taking any type of prescription or over-the-counter medication including but not limited to corticosteroids, non-steroidal anti-inflammatory drugs, and antibiotics within the 14 days prior to the screening visit.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

41 participants in 3 patient groups, including a placebo group

Placebo

Placebo Comparator group

Description:

Placebo group will receive microcrystalline cellulose

Treatment:

Other: Placebo: Microcrystalline Cellulose

Treatment

Active Comparator group

Description:

Treatment group will get 2 g daily of XSurge in microcrystalline cellulose

Treatment:

Dietary Supplement: XSurge

Control Group

Sham Comparator group

Description:

The control group will be included to quantify or describe the effects of the acute exercise training but will not receive any supplement

Treatment:

Other: Control: No supplementation